RxDoctor Payments Data

Tanaporn Rasameesoraj, MD

Sleep Medicine · St Louis Park, MNNPI 1649534496

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,496 of the $1,917 with a category attached, or 78.1%. 20 manufacturers reported payments, led by Medtronic at 25.5% of the total. Reporting peaked in 2020 at $699 and has fallen 92.0% since, to $56 in 2025.

$1,917in general payments, 2019–2025

Across 48 payments — averaging $39.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$489
  • Harmony Biosciences LLC$158
  • MDD US Operations, LLC$147
  • UCB, Inc.$138
  • Amgen$137
  • Eisai Inc.$125
  • plus $724 from 14 others

What the payments were for

  • Travel & lodging$32017%
  • Food & beverage$1,49678%
  • Education$1005%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,917 in reported general payments places this provider in the 85th percentile of 38 sleep medicine providers in Minnesota.

See all sleep medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$146,955
Medicare patients
429
Services billed
7,743

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate58$500,324
NuplazidPimavanserin Tartrate72$386,834
AustedoDeutetrabenazine59$359,848
Tetrabenazine24$106,688
RytaryCarbidopa/Levodopa32$69,831
GocovriAmantadine Hcl23$39,621
UbrelvyUbrogepant38$38,476
Carbidopa-LevodopaCarbidopa/Levodopa1,118$37,332
BriviactBrivaracetam19$24,797
Aimovig AutoinjectorErenumab-Aooe29$21,713
AmantadineAmantadine Hcl268$14,271
Nurtec OdtRimegepant Sulfate13$14,150
NeuproRotigotine15$12,437
Carbidopa-Levodopa ErCarbidopa/Levodopa373$10,273
Primidone246$8,245

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Acadia Pharmaceuticals IncNuplazid$45$386,83472 claims
MDD US Operations, LLCGocovri$147$39,62123 claims
AbbVieUbrelvy$121$38,47638 claims
UCB, Inc.Briviact, Neupro$138$37,23534 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 38 sleep medicine providers in Minnesota.

Other sleep medicine in St Louis Park

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →